Patient characteristics associated with failure of tuberculosis prevention

Tubercle and Lung Disease

Volumn 77, Issue 4, 1996, Pages 308-314

  Menzies, D ^a   Adhikari, N ^b   Tannenbaum, T ^b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL GENERAL HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BCG VACCINATION; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; HAITI; HEALTH; HUMAN; PATIENT COMPLIANCE; SCREENING; TRAINING; TREATMENT FAILURE; TUBERCULIN TEST; TUBERCULOSIS CONTROL; VIET NAM;

EID: 0029763277     PISSN: 09628479     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0962-8479(96)90094-5     Document Type: Article

References (36)

1. Rose D N, Schechter C B, Silver A L. The age threshold for isoniazid chemoprophylaxis: A decision analysis for low risk tuberculin reactors. JAMA 1986; 256: 2709-2713.
2. Taylor W C, Aronson M D, Delbanco T L. Should young adults with a positive tuberculin test take isoniazid? Ann Intern Med 1981; 94: 808-813.
3. Snider D E Jr, Caras G J, Koplan J P. Preventive therapy with isoniazid: Cost-effectiveness of different durations of therapy. JAMA 1986; 255: 1579-1583.
4. Rose D N, Schechter C B, Fahs M C, Silver A L. Tuberculosis prevention: Cost-effectiveness analysis of isoniazid chemoprophylaxis. Am J Prev Med 1988; 4: 102-109.
5. Fitzgerald J M, Gafni A. A cost-effectiveness analysis of the routine use of isoniazid prophylaxis in patients with a positive Mantoux skin test. Am Rev Respir Dis 1990; 142: 848-853.
6. Centers for Disease Control (CDC). Screening for tuberculosis and tuberculous infection in high-risk populations. MMWR 1990; 39 RR-8: 1-7.
7. Centers for Disease Control (CDC). Tuberculosis among foreign-born persons entering the United States: Recommendations of the Advisory Commitee for the Elimination of tuberculosis. MMWR 1990; 39 (no. RR-18).
8. Clague J E, Fields P, Graham D R, Davies P D. Screening for tuberculosis: current practices and attitudes of hospital workers. Tubercle 1991; 72: 265-267.
9. Raad I, Cusick J, Sherertz R J, Sabbagh M, Howell N. Annual tuberculin skin testing of employees at a university hospital: A cost-benefit analysis. Infect Control Hosp Epidemiol 1989: 10: 465-468.
10. Fox W. Compliance of patients and physicians: experience and lessons from tuberculosis - II. Brit Med J 1983; 287: 101-105.
11. Geiseler P J, Nelson K E, Crispen R G. Tuberculosis in physicians: Compliance with preventive measures. Am Rev Respir Dis 1987; 135: 3-9.
12. Adhikari N, Menzies R I. Community-based tuberculin screening programs in Montreal: A cost-outcome description. Am J Public Health 1995; 85: 786-790.
13. Haynes R B. Determinants of Compliance. In: Haynes R B, Wayne T D, Sackett D L, ed. Compliance in Health Care. Baltimore: The John-Hopkins University Press, 1979.
14. Rubels A J, Garro L C. Social and cultural factors in the successful control of tuberculosis. Public Health Rep 1992; 107: 626-636.
15. Sumartojo E. When tuberculosis treatment fails: A social behavioural account of patient adherence. Am Rev Respir Dis 1993; 147: 1311-1320.
16. Barrett-Connor E. The epidemiology of tuberculosis in physicians. JAMA 1979; 241: 33-38.
17. Menzies R I, Vissandjee B. Effect of Bacille Calmette-Guérin vaccination on tuberculin reactivity. Am Rev Respir Dis 1992; 145: 621-625.
18. Menzies R I, Vissandjee B, Amyot D. Factors associated with tuberculin reactivity among the foreign-born in Montreal. Am Rev Respir Dis 1992; 146: 752-756.
19. Menzies R I, Vissandjee B, Rocher I, St Germain Y. The booster effect in two-step tuberculin testing among young adults in Montreal. Ann Intern Med 1994; 120: 190-198.
20. Sokal J E. Measurement of delayed skin-test responses. New Engl J Med 1975; 293: 501-502.
21. Canadian Thoracic Society. Canadian Tuberculosis Standards. 3rd ed. Toronto: Canadian Lung Association, 1988.
22. Carstairs V. Small areas analysis and health service research. Commun Med 1983; 3: 131-139.
23. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am Rev Respir Dis 1994; 149: 1359-1374.
24. Dawson-Saunders B, Trapp R G. Basic and clinical biostatistics. Norwalk: Appleton & Lange, 1990.
25. Kleinbaum D G, Kupper L L. Applied regression analysis and other multi-variate methods. North Scituate: Duxbury Press, 1978.
26. Glassroth J L, Bailey W E, Hopewell P C, Schechter C B, Harden J W. Why is tuberculosis not prevented? Am Rev Respir Dis 1990; 141: 1236-1240.
27. Dash L A, Comstock G W, Flynn J P G. Isoniazid preventive therapy. Am Rev Respir Dis 1980; 121: 1039-1044.
28. Ferebee S H. Controlled chemoprophylaxis trials in tuberculosis. Adv Tuberc Res 1969; 17: 28-106.
29. International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various durations of isoniazid preventive therapy for tuberculosis: Five years of follow-up in the IUAT trial. Bull World Health Organ 1982; 60: 555-564.
30. Westaway M S, Wolmarans L. Cognitive and affective reactions of black urban South Africans towards tuberculosis. Tubercle Lung Dis 1994; 75: 447-453.
31. Leff A, Herskowitz D, Gibert J, Brewin A. Tuberculosis chemoprophylaxis practices in metropolitan clinics. Am Rev Respir Dis 1979; 119: 161-164.
32. Gemson D H, Elinson J E. Prevention in primary care: variability in physician practice patterns in New York City. Am J Prev Med 1986; 2: 226-234.
33. Colice G L. Decision analysis, public health policy, and isoniazid chemoprophylaxis for young adult tuberculin skin reactors. Arch Intern Med 1990; 150: 2517-2522.
34. Tamblyn R M, Battista R. Changing clinical practice: Which interventions work J Cont Educ Hlth Prof 1993; 13.
35. Francis V, Korsch B M, Morris M J. Gaps in doctor-patient communication: patients' response to medical advice. New Engl J Med 1969; 280: 535-540.
36. Hulka B S, Cassel J C, Kupper L L, Burdette J A. Communication, compliance, and concordance between physicians and patients with prescribed medications. Am J Public Health 1976; 66: 847-853.